Trials / Recruiting
RecruitingNCT07307794
To Evaluate the Adhesion of TK-254RX on Healthy Participants
Characterisation of Adhesion Performance of a Newly Developed Esflurbiprofen Topical System (EFTS) - a Phase I, Open-label Study in Healthy Subjects.
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Teikoku Seiyaku Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This study is a single-center, open-label, multiple-dose trial in healthy participants. The primary purpose of this study is to assess the adhesion of TK-254RX. Secondary purposes are to assess the safety of TK-254RX and the residual amount of the patch.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esflurbiprofen Topical System | The total of one TK-254RX per day for 3 days |
Timeline
- Start date
- 2026-01-19
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2025-12-29
- Last updated
- 2026-01-28
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07307794. Inclusion in this directory is not an endorsement.